Key result
Hypertension in asthma is linked to ~4-point lower post-treatment endothelium-dependent vasodilation and higher PASP.
Why the study?
The study aimed to investigate endothelial function and pulmonary artery systolic pressure in asthmatic subjects, including those with concomitant essential hypertension.
Does concomitant essential hypertension affect endothelial function and pulmonary artery systolic pressure in patients with bronchial asthma?
Observational
Does concomitant essential hypertension affect endothelial function and pulmonary artery systolic pressure in patients with bronchial asthma?
In patients with bronchial asthma, impaired endothelial function and elevated pulmonary artery systolic pressure are driven by concomitant essential hypertension rather than asthma severity.
Answers are grounded in this paper and cite their sources.
May support PASP monitoring in asthma with EH; leaves open endothelial mechanisms as therapeutic targets.
Objective. To investigate endothelial function in asthmatic subjects including patients with essential hypertension (EH). Design and methods. The levels of endothelium-dependent and endothelium-independent vasodilation, pulmonary artery systolic pressure (PASP) were evaluated by ultrasound scanner before and after the treatment of the asthma exacerbation. Results. The PASP values before treatment in patients with asthma and concomitant EH (31.3 ± 0.6 mm Hg) and II stage (31.4 ± 0.7 mm Hg) were higher, than in patients with normal blood pressure (28.3 ± 0.6 mm Hg), p < 0.05. The levels of endothelium-dependent vasodilation after treatment in patients with asthma and concomitant EH I stage (11.12 ± 1.00 %) and II stage (10.04 ± 0.88 %) were lower, than in patients with normal blood pressure (15.60 ± 1.58 %), p < 0.05. The levels of endothelium-dependent and endothelium-independent vasodilation, PASP were comparable in patients with different asthma severity. Conclusion. Endothelial function, PASP in asthmatic subjects are related to the presence of concomitant EH.
No takes yet. Share an insight, caveat, or question.
Геннадьевич et al. (2012) conducted an observational in Bronchial asthma with or without concomitant essential hypertension. Concomitant essential hypertension (stage I and II) vs. Asthmatic patients with normal blood pressure was evaluated on Endothelium-dependent vasodilation after treatment of asthma exacerbation (p=< 0.05). Concomitant essential hypertension in asthma was associated with higher baseline PASP and lower post-treatment endothelium-dependent vasodilation.
Synapse has enriched 10 related papers. Consider them for comparative context: